(Q44047918)

29 November 2017

title

Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells (English)

1 reference

29 November 2017

1 reference

lymphoblastic leukemia

1 reference

Suzuki T

1

1 reference

29 November 2017

Coustan-Smith E

series ordinal

2

1 reference

29 November 2017

Mihara K

series ordinal

3

1 reference

29 November 2017

Campana D

series ordinal

4

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

16

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

1276-1284

1 reference

Co-receptor and accessory regulation of B-cell antigen receptor signal transduction.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

1 reference

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Regulatory roles for FcgammaRIII (CD16) and FcgammaRII (CD32) in the development of T- and B-lineage lymphoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Fc gamma receptors in phagocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Characterization of a leukemic cell line of the pre-B phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Ligation of CD38 suppresses human B lymphopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Current recommendations for positive controls in RT-PCR assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Flow cytometric analysis of normal B lymphoid development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Mutations in the mu heavy-chain gene in patients with agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Mutations in Igalpha (CD79a) result in a complete block in B-cell development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

An essential role for BLNK in human B cell development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Signal transduction by human-restricted Fc gamma RIIa involves three distinct cytoplasmic kinase families leading to phagocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Signal transduction via both human low-affinity IgG Fc receptors, Fc gamma RIIa and Fc gamma RIIIb, depends on the activity of different families of intracellular kinases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

An analysis of the presence of Fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia. A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Recent approaches in acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

New definition of remission in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Connections between signal transduction components and cellular responses initiated by antigen receptor on B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Prospect for immunotherapy of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402523

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402523

1 reference

Dimensions Publication ID

29 November 2017

1028466770

0 references

1 reference